GlassScriptPhysician profile
Joshua D Snodgrass
NPI 1447516513
$375.58
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $207 · 2021: $43.21 · 2022: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.37 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $45.28 | 2020 | |
| Tenex Health INC. | $24.88 | 2020 | |
| Avanos Medical | $24.28 | 2020 | |
| Grifols USA, LLC | $23.38 | 2021 | |
| Glaxosmithkline, LLC. | $21.91 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.12 | 2020 | |
| Mylan Specialty L.P. | $14.37 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Snodgrass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.